May 20, 2013   Sweden
nasdaqomx.com: Nasdaq OMX welcomes Diamyd Medical to First North

NASDAQ OMX announces that the trading in Diamyd Medical AB (short name: DMYD B) shares will commence today on First North at NASDAQ OMX Stockholm. Diamyd Medical belongs to the Healthcare sector and is the eighth new company to be admitted to trading on First North in 2013.

Read more here

See interview with CEO Peter Zerhouni

Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research

GAD PRODUCTS